-
A Balancing ActDiabetes increases cancer risk, and a dual diagnosis of cancer and diabetes complicates treatment and prognosis.
by Stephen Ornes
-
Healthy Habits
A Protein PuzzleStudy links higher protein consumption to a greater chance of cancer death, but risk may depend on age.
by Alanna Kennedy-Gorman
-
Forward Look
Push Needed to Increase HPV Vaccination RatesPresident's Cancer Panel stresses reducing 'missed opportunities.'
by Sue Rochman
-
Forward Look
Moving Closer to a Menthol Ban?FDA weighs whether to prohibit sales of mentholated tobacco products.
by Sharon Reynolds
-
Forward Look
Cancer Death Rates Continue to Decline in U.S.Statistics show impact of prevention, early detection and treatment.
by Cameron Walker
-
Forward Look
Clues to Stomach Cancer Discovered in South AmericaFindings could help in cancer prevention.
by Alexandra Goho
-
Palliative Care ExplainedPalliative care can be offered to cancer patients at any point in their illness, beginning with the initial diagnosis. New research points to its effectiveness.
by Melissa Weber
-
Using Old Drugs in New WaysWe already reduce, reuse and recycle. But cancer researchers are exploring a fourth R–repurpose–using drugs approved for treating other diseases to reduce cancer risk and improve outcomes.
by Stephen Ornes
-
Unleashing the Immune SystemNew treatments that harness the power of the immune system are taking aim at many common cancers.
by Alexandra Goho
-
Editor's Letter
The Promise of ImmunotherapyImmunotherapy is a breakthrough in cancer treatment, but more research is needed to broaden its impact.
by Kevin McLaughlin
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
